Heinz-Josef Lenz Selected Research

Heinz-Josef Lenz Research Topics

Disease

237	Neoplasms (Cancer) 05/2024 - 01/2002
206	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2002
32	Colonic Neoplasms (Colon Cancer) 09/2023 - 09/2004
24	Adenocarcinoma 11/2022 - 08/2004
20	Microsatellite Instability 04/2023 - 01/2007
18	Neoplasm Metastasis (Metastasis) 05/2023 - 03/2006
18	Disease Progression 10/2022 - 09/2004
15	Stomach Neoplasms (Stomach Cancer) 09/2022 - 02/2006
13	Rectal Neoplasms (Rectal Cancer) 12/2023 - 01/2005
12	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2003
11	Exanthema (Rash) 10/2020 - 04/2005
10	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 01/2003
9	Leukemia 03/2024 - 11/2005
9	Carcinogenesis 10/2023 - 06/2003
8	Hypertension (High Blood Pressure) 01/2023 - 08/2005
7	Fatigue 01/2023 - 01/2013
7	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2007
7	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2005
7	Neutropenia 02/2019 - 03/2006
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 06/2004
6	Inflammation (Inflammations) 01/2024 - 01/2016
6	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 02/2004
6	Carcinoma (Carcinomatosis) 02/2021 - 03/2005
6	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 01/2010
4	Circulating Neoplastic Cells 09/2021 - 03/2012
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2020 - 07/2008
4	Diarrhea 12/2017 - 05/2008
3	Cholangiocarcinoma 09/2022 - 12/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 10/2013
3	Nausea 10/2020 - 08/2014
3	Vomiting 10/2020 - 08/2004
3	Lung Neoplasms (Lung Cancer) 07/2020 - 06/2004

Drug/Important Bio-Agent (IBA)

57	Bevacizumab (Avastin)FDA Link 03/2024 - 09/2004
55	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2005
54	Cetuximab (Erbitux)FDA Link 03/2024 - 09/2004
46	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024 - 06/2002
40	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 01/2003
37	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2002
35	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2004
33	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2005
26	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2003
21	Monoclonal AntibodiesIBA 03/2024 - 04/2005
20	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2004
19	Messenger RNA (mRNA)IBA 11/2022 - 01/2002
15	Thymidylate SynthaseIBA 01/2019 - 01/2002
14	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2017
14	Gemcitabine FDA Link 10/2020 - 11/2002
14	ParaffinIBA 11/2018 - 03/2005
13	Leucovorin (Folinic Acid)FDA Link 12/2023 - 01/2003
11	Interleukin-8 (Interleukin 8)IBA 04/2015 - 05/2005
10	Phosphotransferases (Kinase)IBA 02/2024 - 04/2007
10	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2002
10	Formaldehyde (Formol)FDA Link 11/2018 - 12/2007
9	RNA (Ribonucleic Acid)IBA 03/2024 - 12/2008
9	LigandsIBA 01/2024 - 06/2007
9	regorafenibIBA 05/2021 - 01/2013
9	Panitumumab (Vectibix)FDA Link 01/2019 - 01/2006
8	PlatinumIBA 01/2022 - 11/2002
8	Epidermal Growth Factor (EGF)IBA 05/2020 - 07/2006
8	AntibodiesIBA 01/2020 - 08/2011
6	NivolumabIBA 03/2024 - 01/2017
6	trifluridine tipiracil drug combinationIBA 02/2019 - 05/2015
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2018 - 05/2005
5	Cell-Free Nucleic AcidsIBA 09/2022 - 08/2015
5	B7-H1 AntigenIBA 01/2022 - 04/2015
5	Vorinostat FDA Link 01/2021 - 07/2009
5	Histone Deacetylase InhibitorsIBA 01/2021 - 07/2009
5	Immunoglobulin G (IgG)IBA 02/2018 - 01/2006
5	Lapatinib (GW572016)FDA Link 01/2016 - 01/2009
5	EnzymesIBA 11/2014 - 01/2002
5	Cisplatin (Platino)FDA LinkGeneric 05/2012 - 01/2003
4	Calcibiotic Root Canal SealerIBA 02/2024 - 01/2019
4	Programmed Cell Death 1 ReceptorIBA 01/2024 - 04/2015
4	Histones (Histone)IBA 01/2023 - 08/2013
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 05/2007
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 03/2012
4	Angiogenesis InhibitorsIBA 01/2020 - 12/2004
4	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 08/2005
4	Thymidine PhosphorylaseIBA 11/2017 - 01/2002
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2015 - 04/2005
4	Codon (Codons)IBA 03/2015 - 03/2003
4	Estrogen ReceptorsIBA 10/2013 - 01/2011
4	PanobinostatIBA 08/2013 - 07/2009
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2013 - 08/2005
4	BilirubinIBA 08/2012 - 08/2004
4	Bortezomib (Velcade)FDA Link 12/2011 - 01/2004
3	Neurotransmitter Agents (Neurotransmitter)IBA 09/2023 - 10/2022
3	Circulating Tumor DNAIBA 01/2023 - 01/2020
3	IpilimumabIBA 10/2022 - 10/2018
3	MicroRNAs (MicroRNA)IBA 06/2020 - 09/2014
3	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2003

Therapy/Procedure

107	Drug Therapy (Chemotherapy) 03/2024 - 06/2002
101	Therapeutics 05/2024 - 10/2003
15	Immunotherapy 01/2024 - 01/2016
7	Adjuvant Chemotherapy 11/2020 - 01/2003
5	Neoadjuvant Therapy 12/2023 - 01/2005
5	Lasers (Laser) 04/2009 - 09/2006
4	Combination Drug Therapy (Combination Chemotherapy) 12/2020 - 06/2002
4	Biological Therapy 12/2019 - 04/2014
4	Radiotherapy 02/2016 - 05/2012